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The intraosseous (IO) route for vascular access was initially described in 1922 \[[@CR1]\] and was used commonly during World War II \[[@CR2]\]. Although the intravascular route is the standard for venous access in medical practice, IO administration of fluids and medications can be an alternative option when the conventional method of intravenous access fails.

Drugs administered intraosseously enter the circulation as fast and in the same concentration as those administered intravenously \[[@CR3], [@CR4]\]. However, there have not been any published clinical trials assessing the use of the EZ-IO™ in the busy emergency department (ED) of a tertiary hospital setting although there have been studies on the paediatric population \[[@CR3]--[@CR11]\].

Intraosseous access has recently been revived in adults as an alternative when conventional intravenous access may be difficult or impossible \[[@CR3], [@CR12]--[@CR15]\]. The standard IO needle has been compared with needles having a newer design and most recently with IO access devices \[[@CR3], [@CR11], [@CR12], [@CR16]--[@CR19]\]. The EZ-IO™ is one such device for adult IO vascular access.

We carried out a non-randomized, prospective, observational study evaluating the use of the EZ-IO™ powered drill device for IO access in adults presenting to a local tertiary ED.

Methods {#Sec2}
=======

We conducted a non-randomized, prospective, observational study in adults using the EZ-IO™ powered drill device. This study was approved by our hospital Ethics Committee. Waiver of consent was obtained as the procedures were deemed to be life saving in the critically ill requiring peripheral access that would not have otherwise been obtained by traditional methods quickly. If the patient was awake enough to understand, verbal and if possible written informed consent was obtained from the patient.

The study population included patients who presented to the Department of Emergency Medicine of Singapore General Hospital (SGH), an urban hospital that is Singapore's oldest and largest acute tertiary hospital and national referral centre.

The SGH Department of Emergency Medicine handles nearly 120,000 patients annually, of which about 9% are resuscitations (priority 1), 33% are major emergencies (priority 2), 56% are ambulant/minor emergencies (priority 3) and 2% are non-emergencies (priority 4).

Inclusion criteria were patients who presented to the ED with age greater than 16 years or \> 40 kg body weight requiring intravenous fluids or medications and in whom an intravenous line could not be established in two attempts or 90 s. They also had to be seriously ill or injured and possess one or more of the following: An altered mental state \[score on the Glasgow Coma Scale (GCS) of 8 or less\]Respiratory compromise \[oxygen saturation (SaO~2~) 80% after appropriate oxygen therapy, respiratory rate \< 10 or \> 40/min\]Haemodynamic instability \[systolic blood pressure (BP) of \< 90\] or profound hypovolaemia (signs and symptoms of shock)Cardiac arrest (medical or traumatic)

Insertion of an IO needle was contraindicated if there was a fracture of the tibia or femur, recent surgery in the extremity to be used or previous orthopaedic procedure (knee replacement) or IO within 24 h (consider alternate tibia), pre-existing medical condition (tumour near insertion site or peripheral vascular disease), infection at insertion site or significant oedema in the extremity to be used. The use of the alternate tibia would be considered in those scenarios. Inability to locate landmarks, significant oedema and excessive tissue at insertion site were relative contraindications to insertion.

The EZ-IO™ utilizes a reusable battery-powered driver and a disposable IO needle set that powers into the IO space by rotating a hollow drill to a preset depth (EZ-IO™ System Driver model number 9050, PD needle set model 9018, AD needle set model 9001, Vidacare Corporation, San Antonio, TX, USA).

Sites of insertion included the tibia and the humerus. The landmark for the insertion point of the proximal tibia is 2 fingerbreadths below the patella and 1--2 cm medial to the tibial tuberosity. The landmark for the insertion point for the proximal humerus is the most prominent aspect of the greater tubercle's outer margins, with the patient's hand on his abdomen to ensure the safest position. A pressure bag device would be applied to the infusion if its rate of infusion was deemed to be too slow.

The outcomes that were assessed included the success rate of EZ-IO™ insertion by operators as defined by the ability to place the IO needle, as well successfully infusing fluids and drugs. Flow rates using normal saline infusion were measured by an independent nurse observer. Methods of IO needle placement confirmation, estimated total time of insertion, fluids and drugs administered, ease of use and the control and function of the EZ-IO™ device, any complications, difficulties in using the device, adverse events to operator and types of malfunction of device were evaluated by a questionnaire.

Placement time was recorded by the individual operator, recorded as the time the operator placed the needle set into the driver till the time the needle was successfully inserted into the bone. The difficulty of insertion was recorded by the physicians on a 10-cm visual analogue scale (VAS) with 0 representing very easy placement and 10 representing very difficult placement.

Only emergency physicians and medical residents who were trained in the use of the EZ-IO™ by completing the manufacturer's training programme and who were familiar with the protocol were allowed to use the device. Standard training for IO insertion was straightforward and lasted less than 2 h. This consisted of a lecture and hands-on training \[[@CR20], [@CR21]\]. The physicians were given instructions on the use of the EZ-IO™ and observed a demonstration on its use on a standard plastic bone model of the tibia as provided for by the manufacturer. The physicians were subsequently allowed multiple practices to obtain IO access using the EZ-IO™ on the plastic bone model.

During the actual IO placement, needle placement was confirmed by visualization of blood on the stylet, ability to aspirate bone marrow, firm placement of the needle in the bone and ability to smoothly deliver a fluid flush. Operators were instructed to give a rapid flush (bolus) of 10 ml of saline with a syringe through the EZ-IO™ once needle placement was confirmed. For conscious patients, a prior flush (bolus) of 20--50 mg 2% lidocaine (preservative free) through the EZ-IO™ was recommended for local anaesthesia.

Patients were followed up until hospital discharge for any complications of IO insertion, including needle displacement, failure of the drill device to function properly, fractures, infection of the insertion site, osteomyelitis, fat embolism, extravasation of fluid or medication and compartment syndrome.

Data were entered using Microsoft Excel 2002 (version 10) and data analysis was performed using SPSS Statistics 15.0. Descriptive frequencies and means/standard deviations are reported as appropriate. Fischer's exact test was used for categorical comparisons and the Mann-Whitney U test for equivalent non-parametric comparisons.

Results {#Sec3}
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From 1 March 2006 to 30 July 2007, 24 patients were recruited. The tibia was the first site of insertion, and a second IO was inserted in the humerus if clinically indicated for the same patient. Although there were 24 patients, there were 24 tibial insertions and 11 humeral insertions on the same patient where clinically indicated for a second peripheral access. The characteristics of the patients are listed in Table [1](#Tab1){ref-type="table"}. Table 1EZ-IO: characteristics of study participants*N* = 24%Age 16--29 years28.3Age 30--59 years625Age \> 60 years1666.7Race Chinese1770.8 Indian416.7 Malay/others312.5Male1250GCS 8--15833.3GCS 3--71666.7Trauma416.7

All EZ-IO™ insertions were successful at the first attempt except for three tibial insertions that were successful on the second attempt. All insertions were firmly placed, with good control of the needle set and separation from the driver.

Table [2](#Tab2){ref-type="table"} shows a comparison between junior operators (residents) and senior operators (attendings). Both groups had 100% success rates for insertion. The average insertion time was less than 5 s for both groups. In our study, the VAS was 1.06. We noted that 88.6% of physicians in our study reported easier insertion with the EZ-IO™ as compared to an intravenous cannula. Table 2Comparison of intraosseous insertions between operatorsResident, *N* = 8 (%)Attending/consultant, *N* = 27 (%)*P* valueEZ-IO placed successfully (%)8 (100.0)27 (100.0)1Multiple attempts needed (%)2 (25)1 (3.7)0.083Visual analogue scale (0--10)1.11.00.920EZ-IO firmly placed (%)8 (100.0)27 (100.0)1Good control of needle set (%)8 (100.0)27 (100.0)1Needle separated from driver easily (%)8 (100.0)27 (100.0)1Stylet separated from needle easily (%)8 (100.0)27 (100.0)1Easier placement with the EZ-IO than an intravenous cannula (%)8 (100.0)23 (85.2)0.553No flow initially1 (12.5)01Low flow rates3 (37.5)1 (2.9)0.030Complications02 (5.7)1Insertion time (average), s3.94.30.862

The junior operators required more repeated attempts and encountered low flow rates as compared to the senior operators.

There were two complications encountered by a senior operator. A glove was caught in the drill device during the IO insertion. The physician had held the IO needle to stabilize the needle's position on the patient's tibia while applying the drill. As such, the glove was caught in the needle and wound around the IO needle as the drill was applied. Another complication encountered was extravasation of infusion fluid at the site of insertion of the IO needle.

Table [3](#Tab3){ref-type="table"} shows the flow rates of intraosseous infusions with and without pressure bag application. Flow rates were significantly faster with a pressure bag than without. Tibial flow rates were 204.6 ml/min with a pressure bag as compared to 68.2 ml/min without a pressure bag, difference −129.5 ml/min \[95% confidence interval (CI): −218.2 to −40.3). Humeral flow rates were significantly faster using a pressure bag (148.1 ml/min) as compared to without (81.8 ml/min), difference −69.6 ml/min (95% CI: −113.9 to −25.3). But the difference of changes ( with or without pressure bag) of flow rate between the tibia and humerus did not show any significance (*P* = 0.157, Mann-Whitney test). Table 3Comparison of flow rates with/without pressure bagFlow rateTibia (*N* = 10), ml/minHumerus (*N* = 8), ml/minNo pressure bag68.2 (42.1)81.8 (38.4)With pressure bag204.6 (156.0)148.1 (75.3)Difference−129.5−69.695% CI−218.2 to −40.3−113.9 to −25.3*P* = 0.157 (Mann-Whitney test)

There were no complications of needle displacement, failure of the drill device to function properly, fractures, infection of the insertion site, osteomyelitis, fat embolism or compartment syndrome.

Discussion {#Sec4}
==========

Available IO devices have included manual needles including the Cook device and the Jamshidi needles, spring-loaded "punch devices" including the First Access for Shock and Trauma (F.A.S.T., Pyng) IO device in the sternum \[[@CR22]\] and the Bone Injection Gun (B.I.G) in the tibia \[[@CR23]\], which has been extensively used by the Israeli military \[[@CR24]\].

Preparation and insertion for the Pyng approaches 50 s \[[@CR22]\] with success rates of 74% for first time users and 95% for experienced users. This may be particularly useful for patients with lower extremity or pelvic trauma \[[@CR25]\]. The B.I.G. is reported to require about 17 s for preparation and insertion \[[@CR26]\]. Preparation and insertion time for the EZ-IO is reported to be approximately 10 s \[[@CR27]\]. Prehospital trials on the EZ-IO device show an 87% success rate. The F.A.S.T.1 device used in the same trial showed 72% success \[[@CR28]\].

In our hospital, the usual practice was to attempt multiple peripheral IV insertions even though access may be difficult or impossible. Central venous access is usually not attempted, as it takes too long as compared to the intraosseous method.

In our study, we had 100% success rates for both junior and senior operators. Intraosseous flow rates were significantly faster with a pressure bag infusion than without.

The IO needle had previously been shown to be a rapid and effective method of vascular access \[[@CR3], [@CR4], [@CR11], [@CR13], [@CR16], [@CR19]\]. We found that even previously inexperienced operators could rapidly and safely insert the IO needle. Previous studies have also shown that emergency drugs and fluids can be rapidly delivered to the systemic circulation, at rates comparable to the intravenous and central venous routes \[[@CR28], [@CR29]\]. All medications and blood products that are approved for IV infusion can be given via an IO access. In our study, the fluids and drugs used included normal saline, dextrose, calcium chloride, atropine, epinephrine, frusemide and ceftriaxone.

The maximum rate of administration through the IO needle was reportedly equivalent to a 21 G peripheral cannula \[[@CR23]\]. The flow rates of an intravenous cannula are typically in the range of 200 (16 G peripheral cannula) to 20 ml/min (24 G peripheral cannula) \[[@CR30]\]. EZ-IO™ tibial flow rates ranged from 20 to over 3,000 ml/h under pressure \[[@CR27]\].

In our study, we found that use of a pressure infusion bag significantly improved fluid flow rates via the IO needle. This is similar to a previous report using paediatric IO needles \[[@CR31]\], although we were able to achieve higher flow rates using adult IO needles, hence subjectively able to provide the necessary volume resuscitation in such circumstances. Pressure pumps improve flow of the IO needle. Flushing of the IO needle after insertion seems to improve flow rates as well \[[@CR27]\].

Various site have been proposed as suitable for IO insertions, including the proximal tibia \[[@CR3], [@CR4], [@CR13]\], distal tibia \[[@CR2]\], sternum \[[@CR4], [@CR12], [@CR13], [@CR22]\], radius \[[@CR32]\], clavicle \[[@CR14]\], proximal humerus and calcaneum \[[@CR33]\]. The proximal tibia and proximal humerus sites were chosen for this study. The proximal tibia site was the initial insertion site of choice, as the landmarks were easily identifiable, superficial, easy to access percutaneously and proximal enough to allow rapid access of fluids or medications into the central circulation. In addition, it is away from vital areas where other resuscitation procedures are ongoing as well as vital structures that might get inadvertently punctured during insertion. For example, the sternal and clavicular sites present problems when airway procedures and cervical immobilization are ongoing in trauma resuscitation. Likewise, the investigators felt that the distal tibia, radius and calcaneum sites would be relatively distal to the central circulation. The proximal humerus was the secondary site, in the event that intravenous cannulation was still unsuccessful after initial resuscitation.

Previously reported complications associated with IO insertions include osteomyelitis \[[@CR34]\], extravasation \[[@CR35]\], fat embolism \[[@CR36]\], compartment syndrome \[[@CR37]\], growth plate abnormalities \[[@CR38]\] and myonecrosis with hypertonic saline infusion \[[@CR39]\]. There were no reported complications with the device in this study, except for two cases. One was where the operator's glove was caught in the IO drill device during insertion. This could be easily prevented by not holding the IO needle during the insertion process but just allowing the drill to insert the IO needle.

Another complication was that of extravasation of fluid at the site of insertion. Extravasation of fluid is the most common complication \[[@CR40]\]. It typically occurs when a needle is misplaced. It seldom occurs with a properly placed needle, and it is associated with excessive movement during or after insertion, which may lead to enlargement of the entry site in the bone relative to the diameter of the needle. Compartment syndrome is a risk with extravasation although our patient did not develop compartment syndrome. The needle must enter through the cortex and into the marrow cavity without passing through the cortex on the other side. If the needle is passed through the opposite cortex, infused fluid enters the calf rather than the venous system. Fluid accumulation may lead to a compartment syndrome. This complication can also be limited by making frequent checks and allowing only one attempt per tibia. Repeated attempts in the same bone allow fluid to flow through the previous holes produced in the bone. Extravasation of hypertonic or caustic medications, such as sodium bicarbonate, dopamine or calcium chloride, can result in necrosis of the muscle.

There were two more cases where ward staff reported difficulty removing the needle. However, the needles were both successfully removed once the correct technique was applied. The correct technique involves using a rotating and pulling movement, rather than rocking the needle, which may cause it to break. Also the needle comes with a Luer lock which can be attached to a syringe to use as a handle for additional traction during removal.

Limitations of the study include the relatively small sample size. In many cases, subsequent intravenous cannulation was successful, once initial resuscitation had been initiated through the tibial IO access.

Also the insertion times were not recorded by an independent observer due to the logistic difficulty of having an investigator present at every resuscitation. We also noted that insertion times may be longer in a true clinical setting, as some time was required to assemble the driver and needle. However, this time is minimal compared to the actual insertion procedure.

The EZ-IO™ allowed medical personnel with little prior experience of adult IO access to be able to achieve successful placement in a fast mean. We also recommend routine use of a pressure infusion bag in order to improve flow rates.

Conclusion {#Sec5}
==========

The EZ-IO™ is a feasible, useful and fast alternative mode of venous access especially in the resuscitation of patients with no venous access or when conventional intravenous access fails. Flow rates may be improved by the use of pressure bags. Complications encountered such as extravasation of fluid and gloves being caught in the drill device can be easily prevented.
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